Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015 …

Objective: To develop an evidence-based guideline for the pharmacologic and
nonpharmacologic treatment of psoriatic arthritis (PsA), as a collaboration between the …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in
2012, but the evidence for these recommendations was only of indirect nature. These …

Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis …

Background Since the publication of the European League Against Rheumatism
recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new …

Psoriatic arthritis (PsA) is a complex inflammatory musculoskeletal and skin disease. The
treatment of PsA has changed substantially over the past 10 years. Clinical practice …

Psoriatic arthritis (PsA) accounts for around 20% of referrals to the early arthritis clinic and
presents a significant diagnostic and management challenge. Early diagnosis is important to …

Objectives To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and
polymyalgia rheumatica (PMR). Methods A systematic literature review was conducted to …

(1) Epidemiologic, clinical, radiologic and serologic evidence suggests that psoriatic arthritis
is a specific entity and not the coincidental occurrence of two common diseases, psoriasis …